A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy

A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy

Currently the main treatment of acute myeloid leukemia (AML) is chemotherapy combining hematopoietic stem cell transplantation. However, the unbearable side effect of chemotherapy and the high risk of life-threatening infections and disease relapse following hematopoietic stem cell transplantation r...

Full description

Bibliographic Details
Main Authors: Luchen Sun, Nanfei Yang, Bing Chen, Yuncheng Bei, Zisheng Kang, Can Zhang, Nan Zhang, Peipei Xu, Wei Yang, Jia Wei, Jiangqiong Ke, Weijian Sun, Xiaokun Li, Pingping Shen
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Mesenchymal stem cell
Acute myeloid leukemia
Extracellular vesicles
Nonsteroidal VDR modulators
Combination therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383523001521

Internet

http://www.sciencedirect.com/science/article/pii/S2211383523001521

Similar Items